Until recently,pregnant women had to undergo amniocentesis, a risky procedure, and to see whether their fetus wasat high risk for Down Syndrome. Now,a routine blood test gives these women the same information.
Mary Harris, WNYC host of Only Human, or Dr. Mary Norton,director of the Program in Genetic and Genomic Prenatal Medicine at the UCSF Fetal Treatment middle, discuss how the tests are changing the way physicians and their patients mediate about pregnancy and disability.
Source: wnyc.org